Search

everythinglearnresearchcommunity

for

Search:↓

Thrombospondin-1 is crucial for hair follicle regression and reduced blood vessel growth during the catagen phase.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Activated autologous platelet-rich plasma can improve healing in diabetic foot ulcers.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Platelet-rich fibrin speeds up burn wound healing in rabbits.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

The 1927 nm fractional thulium laser effectively treats acne by targeting and improving affected skin areas.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.